Trials / Unknown
UnknownNCT04341103
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 500 (estimated)
- Sponsor
- CareDx · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The utilization of AlloSure to help guide immunosuppression management in solid organ transplant recipients diagnosed with COVID-19
Detailed description
An observational case series of patients with solid organ transplants who have been admitted with suspected COVID-19 utilizing AlloSure dd-cf DNA to help guide immunosuppression management balancing the treatment of sepsis and avoiding allograft rejection.
Conditions
Timeline
- Start date
- 2020-04-01
- Primary completion
- 2020-12-01
- Completion
- 2021-03-01
- First posted
- 2020-04-10
- Last updated
- 2020-04-10
Source: ClinicalTrials.gov record NCT04341103. Inclusion in this directory is not an endorsement.